It doesn't predict what a specific individual will experience with a compounded formulation
We provide free case reviews, and we do not charge any upfront legal fees to meet with or hire us
Your medical provider must write a prescription, indicating it is to be compounded for you
Overview Retatrutide is a synthetic peptide investigated in laboratory research for its ability to engage three distinct metabolic signaling pathways: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Many report feeling fuller faster, experiencing fewer cravings, and noticing improvements in bloating and energy balance after consistent use
Published trial endpoints show meaningful changes over months, with major body-weight endpoints measured at 24, 48, 68, 80, and 104 weeks